International Clinical Trial: Feasibility of a Lifestyle Intervention to Switch to a High-fiber, Gut-healthy Diet in Women With Triple-negative Breast Cancer Undergoing Neoadjuvant Immunotherapy: a Randomized Controlled Trial

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07311083) titled 'Feasibility of a Lifestyle Intervention to Switch to a High-fiber, Gut-healthy Diet in Women With Triple-negative Breast Cancer Undergoing Neoadjuvant Immunotherapy: a Randomized Controlled Trial' on Dec. 16, 2025.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Kliniken Essen-Mitte

Condition: Microbiome

Intervention: Dietary Supplement: switching to a high-fibre diet

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: February 1, 2026

Target Sample Size: ...